Modification of infarct material properties limits adverse ventricular remodeling.
about
Physiological Implications of Myocardial Scar StructureWhy Is Infarct Expansion Such an Elusive Therapeutic Target?Experimental and computational investigation of altered mechanical properties in myocardium after hydrogel injection.Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium.Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: relation to left ventricular remodelingInjectable microsphere gel progressively improves global ventricular function, regional contractile strain, and mitral regurgitation after myocardial infarction.A novel method for quantifying the in-vivo mechanical effect of material injected into a myocardial infarction.Estimating passive mechanical properties in a myocardial infarction using MRI and finite element simulationsMRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking.Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardiumDynamic assessment of mitral annular force profile in an ovine model.Localized targeting of biomaterials following myocardial infarction: a foundation to build onA model to determine the effect of collagen fiber alignment on heart function post myocardial infarction.The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction.An integrated inverse model-experimental approach to determine soft tissue three-dimensional constitutive parameters: application to post-infarcted myocardium.Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences.In-Vivo Assessment of Regional Mechanics Post-Myocardial Infarction: A Focus on the Road Ahead.Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.Bioactive electrospun fibers of poly(glycerol sebacate) and poly(ε-caprolactone) for cardiac patch application.Cell-Extracellular Matrix Mechanobiology: Forceful Tools and Emerging Needs for Basic and Translational Research.Protein/polysaccharide-based scaffolds mimicking native extracellular matrix for cardiac tissue engineering applications.Computational sensitivity investigation of hydrogel injection characteristics for myocardial support.Sonomicrometry-Based Analysis of Post-Myocardial Infarction Regional Mechanics.An integrated electromechanical-growth heart model for simulating cardiac therapies.
P2860
Q28085424-5849FD2A-0E00-4306-AE1A-DAF34EF1AB59Q30278655-25BF303D-D620-4C2A-9F72-B001B93B83C2Q33655418-BE57128E-9AE1-4929-A5D4-FDA0E0142A26Q33951374-D04C3835-CA03-4F34-AF9F-04C7F3DE5619Q34050245-E91C50C0-AFA8-4481-815B-E2D3D1F66C2BQ34065859-A11BB040-4529-4AC4-93F9-AE0C95EF701DQ34125089-56BF3450-A1B5-4693-9AAE-39FEED6CEC8BQ35039708-32850067-61D9-470D-9024-B325FB733D3DQ35250109-D235288F-5636-4993-9102-725F75D3D616Q35433714-04EA35DF-DDBC-437C-B366-056476195A28Q36016748-80DFFC2A-F54D-4E65-87C2-A66CEA9E8F2FQ36128346-F9F61470-8370-4918-83DC-4E357654C40BQ36260404-7ABADB99-F179-4F75-AEB0-0F1DC46FFEBBQ36781790-5254B7E7-B22F-45E5-94B8-1AEB05694E56Q37170581-511285D1-029F-4129-976B-84459793BC91Q37558186-7C039BF5-614F-4387-B0D1-EF41C2D30E0DQ38177694-5E243DE0-A662-4532-8553-FDA1B6D74403Q38598418-502A96A1-8CB0-4732-B474-4CBBEC73D68EQ38742092-C94BC0BE-FA5C-45AE-B4B5-75ED9F76227AQ39149965-08E8F909-63F5-4B6C-9499-E5FA1132F7FBQ39197932-CEF98046-DF6D-4D92-AD82-774BA8F184B3Q43715154-FAE5E03E-865D-4FFA-A955-DA5E17755B27Q45385684-5E84C1DB-4165-496E-92E3-A71580EEFAF9Q47310923-E7DAA94E-C9A9-4913-98DA-8781167B4AC5Q47427132-093C5988-79FC-4B37-8B3A-B9355508C726Q47694285-9AAA26B7-E563-4F6B-AC7D-DF5C4485EBD6Q48048972-379480AD-B913-4857-B7BB-56C3E21D365FQ51717947-77462CAF-42C2-4E15-AE54-86E85AAEC617
P2860
Modification of infarct material properties limits adverse ventricular remodeling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Modification of infarct material properties limits adverse ventricular remodeling.
@ast
Modification of infarct material properties limits adverse ventricular remodeling.
@en
type
label
Modification of infarct material properties limits adverse ventricular remodeling.
@ast
Modification of infarct material properties limits adverse ventricular remodeling.
@en
prefLabel
Modification of infarct material properties limits adverse ventricular remodeling.
@ast
Modification of infarct material properties limits adverse ventricular remodeling.
@en
P2093
P2860
P1476
Modification of infarct material properties limits adverse ventricular remodeling.
@en
P2093
Benjamin M Jackson
Chad E Eckert
Jason A Burdick
Joseph H Gorman
Kanji Matsuzaki
Liam P Ryan
Masato Morita
Michael S Sacks
Robert C Gorman
P2860
P304
P356
10.1016/J.ATHORACSUR.2011.04.051
P407
P577
2011-08-01T00:00:00Z